Brad MitchellMar 275 minPROG | Preecludia Competition $3-6 a share possible this week Description of Competition and announcement of a possible double in share price this week.
Brad MitchellFeb 243 minPROG | 02.23.22Update the flow of the business and current events. Discussion at the end.
Brad MitchellFeb 136 minPROG | Hidden AssetsOptifinancial Newsletter - Knowledge is power - Brad Mitchell This is not financial advice nor recommendations. This is purely our own...
Brad MitchellJan 169 minPROG | Preecludia, Fraud or not?Preecludia | Fraud or not? This article dives into the legitimacy of Progenity's product
Brad MitchellDec 26, 20219 minPROG | Understanding topline results before release this weekDescription of the studies for you knowledge and how it will effect share price upon release of results
Brad MitchellDec 12, 20217 minRani vs ProgenityOptifinancial Newsletter - Knowledge is power - Brad Mitchell This is not financial advice nor recommendations. This is purely our own...
Brad MitchellNov 30, 202146 minItinerary | PROG Wednesday Night Twitter Call Itinerary for upcoming Twitter Spaces call
Brad MitchellNov 28, 202110 min3 Tech Pills & Catalyst TimelinesClarification on the product lines for Progenity and near term catalysts in the future.
Brad MitchellNov 21, 20216 minProgenity | Upcoming catalysts, competition is good newsProgenity to dominate the market during end of year. Price appreciation is on the horizon due to market reevaluation and catalysts ahead.
Brad MitchellSep 5, 20216 minProgenity and EthereumIN THIS ISSUE Progenity This small biotechnology company has fallen from $15 a share to $1 a share in one year. We think this can go to...
Brad MitchellJul 18, 20217 minProgenity and DisneyIN THIS ISSUE Progenity This company is developing groundbreaking medical technology. Learn why we think now is a good time to buy....
Brad MitchellMay 30, 20217 minProgenity Inc.Please subscribe to us, we are worth your time and will keep you informed! RECAP OF LAST WEEK AND RESULTS: Cassava Sciences This company...